Joseph Balestrieri

Recommended Articles

• What are Bilateral Cataracts?

  The lenses of healthy eyes are usually clear. Cataracts occur when a person's lenses become cloudy and opaque. Cataracts can affect both eyes at the same time, called bilateral cataracts. Bilateral cataracts are very common, but cataracts must occur on their own and cannot spread from one eye to the...

• The Link Between Mononucleosis and Multiple Sclerosis

  For anyone suffering from Multiple Sclerosis (MS), one of the most frustrating parts of the disease is not knowing how, why, or when the disease began. Many patients with multiple sclerosis have had the disease and not known about it for years, others have had it diagnosed right out of the blue....

• What Conditions Does a Bone Doctor Treat?

  What is a bone doctor?A bone doctor is also known as an orthopedist or an orthopedic surgeon. Bone doctors specialize in the diagnosis and treatment of musculoskeletal injuries, diseases, and conditions. Their practice is also seen in other areas, such as pediatrics, sports medicine, trauma,...

• Is Bacterial Meningitis Serious? Know the Symptoms of Meningitis

  What is Meningitis?Meningitis is the swelling or inflammation of the meninges, which are the three specific membranes covering the brain and the spinal cord. The primary function of the meninges is to protect the central nervous system. Meningitis is an uncommon infection that affects the delicate...

• New Drug for Parkinson's Disease Approved by FDA

  The US Food and Drug Administration (FDA) recently passed a new drug called amantadine extended release capsules to treat dyskinesia in those who have Parkinson’s disease and  are also on medication therapy. The Michael J. Fox Foundation recently created the UNDRS or Unified Dyskinesia Rating...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...